ONCO
Onconetix Inc
NASDAQ: ONCO · HEALTHCARE · BIOTECHNOLOGY
$0.64
-8.57% today
Updated 2026-05-01
Market cap
$514220.00
P/E ratio
—
P/S ratio
0.63x
EPS (TTM)
$-82.80
Dividend yield
—
52W range
$1 – $54
Volume
9.4M
Onconetix Inc (ONCO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-825126.00 | $-1.73M | $-2.04M | $-8.68M | $-13.58M | $-10.50M | $-9.68M |
| Capital expenditures | $4500.00 | $11792.00 | $1924.00 | $9339.00 | $55044.00 | $28471.00 | $0.00 |
| Depreciation | $573.00 | $3056.00 | $4890.00 | $6752.00 | $43937.00 | $731345.00 | — |
| Stock-based comp | $3266.00 | $334837.00 | $130141.00 | $1.97M | $329760.00 | $438653.00 | $74267.00 |
| Free cash flow | $-829626.00 | $-1.74M | $-2.05M | $-8.68M | $-13.64M | $-10.52M | $-9.68M |
| Investing cash flow | $-4500.00 | $-11792.00 | $-1924.00 | $-32665.00 | $-8.65M | $-28471.00 | — |
| Financing cash flow | $6.88M | $0.00 | $-334188.00 | $32.53M | $1.04M | $6.74M | — |
| Dividends paid | — | — | — | — | — | $206404.00 | $409510.00 |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |